Prophase Labs ( (PRPH) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ProPhase Labs, Inc. has filed a Form 12b-25 to notify investors of a delay in submitting its Annual Report on Form 10-K (Yearly Report) for the fiscal year ended December 31, 2025. The delayed filing concerns the company’s yearly financial statements and related disclosures required for U.S. public companies.
The company attributes the delay mainly to additional time needed to complete its year-end financial reporting process. This includes finalizing its income tax provision and allowing its independent registered public accounting firm to complete ongoing audit procedures.
ProPhase Labs states that it is working closely with its auditors and expects to file the Form 10-K (Yearly Report) within the standard fifteen-day extension window allowed under SEC Rule 12b-25. This suggests the company anticipates resolving the outstanding work in the near term rather than facing a prolonged delay.
The company does not anticipate any significant change in results of operations compared with the prior fiscal year based on information available at this time. Investors should note that these expectations are inherently forward-looking and could change once the audit and income tax calculations are fully completed.
ProPhase Labs confirms that all other required periodic SEC reports have been filed over the past 12 months, indicating ongoing compliance with its regular reporting obligations. The notification was signed on March 27, 2026, by Ted Karkus, Chairman of the Board and Chief Executive Officer, underscoring executive-level oversight of the filing delay and remediation efforts.
The most recent analyst rating on (PRPH) stock is a Sell with a $0.20 price target. To see the full list of analyst forecasts on Prophase Labs stock, see the PRPH Stock Forecast page.
Spark’s Take on PRPH Stock
According to Spark, TipRanks’ AI Analyst, PRPH is a Neutral.
The score is held down primarily by weak financial performance (sharp revenue contraction, persistent losses, and negative cash flows) and bearish trend signals (price below major moving averages with negative MACD). Potential upside catalysts from the earnings call and recent financing/listing developments provide some offset, but execution and liquidity/dilution risks remain material.
To see Spark’s full report on PRPH stock, click here.
More about Prophase Labs
ProPhase Labs, Inc. is a U.S.-based company headquartered in Uniondale, New York. It is listed with SEC file number 000-21617 and CUSIP 74345W108, and files regular reports as a public registrant under the Securities Exchange Act of 1934.
Average Trading Volume: 423,396
Technical Sentiment Signal: Strong Sell
Current Market Cap: $683.5K
Find detailed analytics on PRPH stock on TipRanks’ Stock Analysis page.